Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies

NCT02912845 is registered in ClinicalTrials.gov with Kamada, Ltd. as lead sponsor.

NCT NCT02912845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02912845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
Lead sponsor
Kamada, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2016
Completion date
November 13, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rabies